← Back to Search

Fasting for Type 1 Diabetes

N/A
Recruiting
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a diagnosis of type 1 diabetes
Non-obese (BMI < or = to 30)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure, up to 2.5 hours
Awards & highlights

Study Summary

This trial will study how fasting affects insulin-induced hypoglycemia in people with type 1 diabetes, to see how it impacts their body's response.

Who is the study for?
This trial is for non-obese individuals with type 1 diabetes, who have a C-peptide negative status. It's open to all genders and ethnicities, provided they don't smoke or have complications like neuropathy, retinopathy, nephropathy, HIV/hepatitis, cardiovascular diseases or are on certain medications like steroids or beta-blockers.Check my eligibility
What is being tested?
The study investigates how fasting affects the body's response to low blood sugar in people with type 1 diabetes. Participants will undergo periods of fasting and feeding to see how these states influence their hormonal and liver responses during insulin-induced hypoglycemia.See study design
What are the potential side effects?
While not explicitly stated in the information given, potential side effects may include symptoms related to hypoglycemia such as dizziness, confusion, sweating, hunger and possibly fainting during the fasting intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with type 1 diabetes.
Select...
My BMI is 30 or less.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure, up to 2.5 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure, up to 2.5 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucagon
Glucose infusion rate
Hepatic glucose production
Secondary outcome measures
Epinephrine
Peripheral glucose uptake
Other outcome measures
Cortisol
Growth Hormone

Trial Design

2Treatment groups
Experimental Treatment
Group I: FeedingExperimental Treatment1 Intervention
Subjects will eat a normal breakfast and lunch prior to insulin-induced hypoglycemia.
Group II: FastingExperimental Treatment1 Intervention
Subjects will remain fasted prior to insulin-induced hypoglycemia.

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,384 Total Patients Enrolled

Media Library

Fasting Clinical Trial Eligibility Overview. Trial Name: NCT05973799 — N/A
Low Blood Sugar Research Study Groups: Fasting, Feeding
Low Blood Sugar Clinical Trial 2023: Fasting Highlights & Side Effects. Trial Name: NCT05973799 — N/A
Fasting 2023 Treatment Timeline for Medical Study. Trial Name: NCT05973799 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial accessible to participants aged less than 85 years?

"The age of eligibility for this medical trial is between 18 and 45, as specified in the inclusion criteria."

Answered by AI

How many individuals has the study accepted to this date?

"Affirmative. Information hosted on clinicaltrials.gov verifies that this research endeavor, which was originally posted on October 10th 2019, is actively recruiting participants. This experiment requires the recruitment of approximately ten individuals from a single medical centre."

Answered by AI

Is there availability for additional participants in this clinical trial?

"Indeed, clinicaltrials.gov reports that this medical trial is currently welcoming participants. The experiment was first registered on October 10th 2019 and last edited on July 25th 2023."

Answered by AI

Might I be eligible to join this investigation?

"This clinical trial is in search of approximately 10 individuals who have low blood sugar levels and are aged between 18 to 45."

Answered by AI

Who else is applying?

What site did they apply to?
University of Cincinnati
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes
Jason Winnick 2019. "Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05973799.
All > Hypoglycemia
~1 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top